IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR ( FACTOR 8 )

[1] ABILDGAARD C F, 1962, Pediatr Clin North Am, V9, P819

[2] SURVIVAL OF FACTOR VIII (ANTIHEMOPHILIC GLOBULIN) AND FACTOR IX (PLASMA THROMBOPLASTIN COMPONENT) IN NORMAL HUMANS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1963, 42 (07) : 1040 - &

[3] PHYSIOLOGICAL BASIS FOR TRANSFUSION THERAPY IN HEMORRHAGIC DISORDERS - A CRITICAL REVIEW [J]. TRANSFUSION, 1961, 1 (02) : 71 - +

[4] BIGGS R, 1957, LANCET, V2, P311

[5] BLOMBACK M, 1958, ACTA MED SCAND, V161, P301

[6] BLOMBACK M, 1958, ACTA PAEDIAT UPPSA S, P114

[7] BRINKHOUS KM, 1956, ARCH PATHOL, V61, P6

[8] DOUGLAS AS, 1958, J LAB CLIN MED, V51, P850

[9] ERLANDSON ME, 1958, PEDIATRICS, V22, P910

[10] KEKWICK RA, 1957, LANCET, V1, P647

[1] ABILDGAARD C F, 1962, Pediatr Clin North Am, V9, P819

[2] SURVIVAL OF FACTOR VIII (ANTIHEMOPHILIC GLOBULIN) AND FACTOR IX (PLASMA THROMBOPLASTIN COMPONENT) IN NORMAL HUMANS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1963, 42 (07) : 1040 - &

[3] PHYSIOLOGICAL BASIS FOR TRANSFUSION THERAPY IN HEMORRHAGIC DISORDERS - A CRITICAL REVIEW [J]. TRANSFUSION, 1961, 1 (02) : 71 - +

[4] BIGGS R, 1957, LANCET, V2, P311

[5] BLOMBACK M, 1958, ACTA MED SCAND, V161, P301

[6] BLOMBACK M, 1958, ACTA PAEDIAT UPPSA S, P114

[7] BRINKHOUS KM, 1956, ARCH PATHOL, V61, P6

[8] DOUGLAS AS, 1958, J LAB CLIN MED, V51, P850

[9] ERLANDSON ME, 1958, PEDIATRICS, V22, P910

[10] KEKWICK RA, 1957, LANCET, V1, P647